These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 34167436)
1. miR-4486 enhances cisplatin sensitivity of gastric cancer cells by restraining the JAK3/STAT3 signalling pathway. Zhou C; Chen L; Chen R; Xu F; Huang Z; Huang R; Wang W; Xu Q J Chemother; 2022 Feb; 34(1):35-44. PubMed ID: 34167436 [TBL] [Abstract][Full Text] [Related]
2. miR-34a regulates cisplatin-induce gastric cancer cell death by modulating PI3K/AKT/survivin pathway. Cao W; Yang W; Fan R; Li H; Jiang J; Geng M; Jin Y; Wu Y Tumour Biol; 2014 Feb; 35(2):1287-95. PubMed ID: 24068565 [TBL] [Abstract][Full Text] [Related]
3. MiR-124 changes the sensitivity of lung cancer cells to cisplatin through targeting STAT3. Qi MM; Ge F; Chen XJ; Tang C; Ma J Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5242-5250. PubMed ID: 31298375 [TBL] [Abstract][Full Text] [Related]
4. RKIP promotes cisplatin-induced gastric cancer cell death through NF-κB/Snail pathway. Liu H; Li P; Li B; Sun P; Zhang J; Wang B; Jia B Tumour Biol; 2015 Mar; 36(3):1445-53. PubMed ID: 25547433 [TBL] [Abstract][Full Text] [Related]
5. Targeted Regulation of FoxO3a by miR-372 to Mediate Gastric Carcinoma Cell Apoptosis and DDP Drug Resistance. Wang C; Wang C; Qiu C; Su Z Cancer Biother Radiopharm; 2020 Dec; 35(10):753-759. PubMed ID: 32379491 [No Abstract] [Full Text] [Related]
6. MiR-26a enhances the sensitivity of gastric cancer cells to cisplatin by targeting NRAS and E2F2. Wen L; Cheng F; Zhou Y; Yin C Saudi J Gastroenterol; 2015; 21(5):313-9. PubMed ID: 26458859 [TBL] [Abstract][Full Text] [Related]
7. miR-149 reverses cisplatin resistance of gastric cancer SGC7901/DDP cells by targeting FoxM1. Li X; Liang J; Liu YX; Wang Y; Yang XH; Luan BH; Zhang GL; Du J; Wu XH Pharmazie; 2016 Nov; 71(11):640-643. PubMed ID: 29441968 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-206 facilitates gastric cancer cell apoptosis and suppresses cisplatin resistance by targeting MAPK2 signaling pathway. Chen Z; Gao YJ; Hou RZ; Ding DY; Song DF; Wang DY; Feng Y Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):171-180. PubMed ID: 30657558 [TBL] [Abstract][Full Text] [Related]
9. Baicalein enhanced cisplatin sensitivity of gastric cancer cells by inducing cell apoptosis and autophagy via Akt/mTOR and Nrf2/Keap 1 pathway. Li P; Hu J; Shi B; Tie J Biochem Biophys Res Commun; 2020 Oct; 531(3):320-327. PubMed ID: 32800561 [TBL] [Abstract][Full Text] [Related]
10. Downregulation of microRNA-4295 enhances cisplatin-induced gastric cancer cell apoptosis through the EGFR/PI3K/Akt signaling pathway by targeting LRIG1. Yan R; Li K; Yuan DW; Wang HN; Zhang Y; Dang CX; Zhu K Int J Oncol; 2018 Dec; 53(6):2566-2578. PubMed ID: 30320337 [TBL] [Abstract][Full Text] [Related]
11. MiR-876-3p regulates cisplatin resistance and stem cell-like properties of gastric cancer cells by targeting TMED3. Peng C; Huang K; Liu G; Li Y; Yu C J Gastroenterol Hepatol; 2019 Oct; 34(10):1711-1719. PubMed ID: 30843262 [TBL] [Abstract][Full Text] [Related]
12. Lidocaine alleviates cisplatin resistance and inhibits migration of MGC-803/DDP cells through decreasing miR-10b. Zhang X; Gu G; Li X; Zhang C Cell Cycle; 2020 Oct; 19(19):2530-2537. PubMed ID: 32892697 [TBL] [Abstract][Full Text] [Related]
13. BI2536, a potent and selective inhibitor of polo-like kinase 1, in combination with cisplatin exerts synergistic effects on gastric cancer cells. Lian G; Li L; Shi Y; Jing C; Liu J; Guo X; Zhang Q; Dai T; Ye F; Wang Y; Chen M Int J Oncol; 2018 Mar; 52(3):804-814. PubMed ID: 29393385 [TBL] [Abstract][Full Text] [Related]
14. Effect of PLK1 inhibition on cisplatin-resistant gastric cancer cells. Chen Z; Chai Y; Zhao T; Li P; Zhao L; He F; Lang Y; Qin J; Ju H J Cell Physiol; 2019 May; 234(5):5904-5914. PubMed ID: 30488440 [TBL] [Abstract][Full Text] [Related]
15. Exosome-Derived Circ-PVT1 Contributes to Cisplatin Resistance by Regulating Autophagy, Invasion, and Apoptosis Via miR-30a-5p/YAP1 Axis in Gastric Cancer Cells. Yao W; Guo P; Mu Q; Wang Y Cancer Biother Radiopharm; 2021 May; 36(4):347-359. PubMed ID: 32799541 [No Abstract] [Full Text] [Related]
16. MiR-187 influences cisplatin-resistance of gastric cancer cells through regulating the TGF-β/Smad signaling pathway. Zhu QL; Li Z; Lv CM; Wang W Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9907-9914. PubMed ID: 31799659 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-95-3p serves as a contributor to cisplatin resistance in human gastric cancer cells by targeting EMP1/PI3K/AKT signaling. Ni Q; Zhang Y; Tao R; Li X; Zhu J Aging (Albany NY); 2021 Mar; 13(6):8665-8687. PubMed ID: 33714198 [TBL] [Abstract][Full Text] [Related]
18. MiR-503 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R and BCL2. Wang T; Ge G; Ding Y; Zhou X; Huang Z; Zhu W; Shu Y; Liu P Chin Med J (Engl); 2014; 127(12):2357-62. PubMed ID: 24931256 [TBL] [Abstract][Full Text] [Related]
19. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a. Cheng C; Qin Y; Zhi Q; Wang J; Qin C Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of autophagy improves resistance and enhances sensitivity of gastric cancer cells to cisplatin. Hou G; Bai Y; Jia A; Ren Y; Wang Y; Lu J; Wang P; Zhang J; Lu Z Can J Physiol Pharmacol; 2020 Jul; 98(7):449-458. PubMed ID: 32058824 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]